|
⚲
|
| Keyboard |
| Recursion Pharmaceuticals Inc | |
|---|---|
| Ticker | RXRX |
| CIK # | 0001601830 |
| CUSIP | 75629V104 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | 41S Rio Grande Street, Salt Lake City, UT 84101 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Recursion Pharmaceuticals Inc | 2020-09-15 | 245.9 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| Recursion Pharmaceuticals LLC | 2015-12-04 | 2.6 M | Exemption: 506(b) · Minimum: $5,000 · Remaining: $50,000 · Duration: One year or less · Revenue: $1 - $1,000,000 |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001601830] | 10-K | |
| [0001601830] | 10-Q | |
| [0001601830] | 3 | |
| [0001601830] | 4 | |
| [0001601830] | 8-K | |
| [0001601830] | D | |
| [0001601830] | SC 13D | |
| [0001601830] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Gibson Christopher
Class A Common Stock
|
2026-03-23 | Conversion | 40,000 | $0.00 | |
|
Gibson Christopher
Class B Common Stock · derivative
|
2026-03-23 | Conversion | 40,000 | $0.00 | |
|
Gibson Christopher
Class A Common Stock
|
2026-03-23 | Sell | 40,000 | $3.25 | 130,000 |
|
Taylor Ben R
Class A Common Stock
|
2026-03-17 | Sell | 7,956 | $3.39 | 26,971 |
|
Taylor Ben R
Class A Common Stock
|
2026-03-16 | Tax withheld | 7,075 | $3.42 | 24,196 |
|
Gibson Christopher
Class B Common Stock · derivative
|
2026-03-09 | Conversion | 20,000 | $0.00 | |
|
Gibson Christopher
Class A Common Stock
|
2026-03-09 | Conversion | 20,000 | $0.00 | |
|
Gibson Christopher
Class A Common Stock
|
2026-03-09 | Gift | 20,000 | $0.00 | |
|
Khan Najat
Class A Common Stock
|
2026-03-09 | Sell | 28,298 | $3.35 | 94,798 |
|
Borgeson Blake
Class A Common Stock
|
2026-03-03 | Sell | 170,000 | $3.46 | 588,200 |
|
Gibson Christopher
Class A Common Stock
|
2026-02-19 | Sell | 40,000 | $3.46 | 138,400 |
|
Gibson Christopher
Class A Common Stock
|
2026-02-19 | Conversion | 40,000 | $0.00 | |
|
Gibson Christopher
Class B Common Stock · derivative
|
2026-02-19 | Conversion | 40,000 | $0.00 | |
|
Taylor Ben R
Class A Common Stock
|
2026-02-18 | Sell | 13,426 | $3.08 | 41,352 |
|
Taylor Ben R
Class A Common Stock
|
2026-02-17 | Tax withheld | 11,908 | $3.49 | 41,559 |
|
Gibson Christopher
Class A Common Stock
|
2026-02-17 | Tax withheld | 27,265 | $3.49 | 95,155 |
|
Hallett David
Class A Common Stock
|
2026-02-17 | Tax withheld | 11,908 | $3.49 | 41,559 |
|
Khan Najat
Class A Common Stock
|
2026-02-17 | Tax withheld | 14,280 | $3.49 | 49,837 |
|
Gibson Christopher
Class A Common Stock
|
2026-02-06 | Tax withheld | 10,364 | $3.56 | 36,896 |
|
Khan Najat
Class A Common Stock
|
2026-02-06 | Grant | 30,346 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 339 | 343,075,229 |
| 2025-12-31 | 337 | 339,029,176 |
| 2025-09-30 | 329 | 342,049,410 |
| 2025-06-30 | 337 | 324,619,356 |
| 2025-03-31 | 345 | 313,012,393 |
| 2024-12-31 | 322 | 310,424,930 |
| 2024-09-30 | 271 | 268,402,639 |
| 2024-06-30 | 273 | 255,552,597 |
| 2024-03-31 | 251 | 219,930,000 |
| 2023-12-31 | 203 | 209,975,238 |
| 2023-09-30 | 195 | 152,789,925 |
| 2023-06-30 | 159 | 126,308,633 |